Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Conmed Corp Issues Q4 2013 Guidance Below Analysts' Estimates; Lowers FY 2013 Guidance


Thursday, 24 Oct 2013 07:00am EDT 

Conmed Corp announced that for the fourth quarter 2013, it expects sales of $195 - $200 million resulting in a total fiscal 2013 sales forecast of $754 - $759 million versus prior range of $770 - $775 million. At these sales levels, the Company forecast fourth quarter of 2013 adjusted earnings per share of $0.47 - $0.52 resulting in fiscal 2013 adjusted earnings per share forecast of $1.75 - $1.80 as compared to the previous total year guidance range of $1.80 - $1.85. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $1.82 and revenue of $772 million for fiscal 2013; and revenue of $206 million and EPS of $0.54 the fourth quarter of 2013. 

Company Quote

53.02
 --
6 May 2015